Premium Aprocitentan API in Pakistan: Raw Material for Pharmaceutical Formulators

Premium Aprocitentan API in Pakistan: Raw Material for Pharmaceutical Formulators

Product Name: Aprocitentan (Active Pharmaceutical Ingredient)

Brand/Supplier: Morgan

Therapeutic Category: Dual Endothelin Receptor Antagonist (ETRA)

Indications: Resistant Hypertension

Compliance Notice: This technical catalog is intended exclusively for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Aprocitentan supplied by Morgan is a highly purified Active Pharmaceutical Ingredient (API) strictly for commercial formulation and R&D. It is not a finished medicine.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Aprocitentan is an orally active, small-molecule Active Pharmaceutical Ingredient (API) classified as a dual Endothelin Receptor Antagonist (ETRA). In cardiovascular pharmacology, it is utilized to address severe vascular pathologies that do not respond to conventional therapies.

Unlike standard antihypertensive classes (such as calcium channel blockers or renin-angiotensin system inhibitors), Aprocitentan targets the endothelin pathway. It functions by competitively inhibiting the binding of endothelin-1 (ET-1) to both endothelin type-A (ETA) and type-B (ETB) receptors. In patients with resistant hypertension, the endothelin system is typically overactive, leading to persistent vasoconstriction and vascular hypertrophy.

By blocking these receptors, Aprocitentan facilitates vasodilation and lowers systemic blood pressure. In finished dosage forms—typically formulated as a 12.5 mg oral tablet—this API is indicated as an add-on treatment for resistant hypertension in patients whose blood pressure remains uncontrolled despite the use of three or more standard antihypertensive medications.

Sourcing Aprocitentan Pakistan: Morgan’s Supply Network

For pharmaceutical formulation facilities in the region, relying on overseas API procurement can introduce variability in lead times and complicate regulatory approvals. Procuring Aprocitentan Pakistan through Morgan’s localized supply network provides distinct operational advantages for commercial manufacturing.

We supply pilot-scale and commercial-scale quantities synthesized in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines for active pharmaceutical ingredients.

Partnering with Morgan provides your procurement and R&D teams with the following provisions:

• DRAP Registration Support: We supply comprehensive regulatory documentation, including the open parts of the Drug Master File (DMF), detailed impurity profiles, and accelerated stability data. This facilitates streamlined dossier submissions to the Drug Regulatory Authority of Pakistan (DRAP).
• Supply Chain Stability: By maintaining local API inventory, Morgan eliminates international transit delays and customs clearance variables, ensuring your commercial batch schedules are met.
• Batch-to-Batch Uniformity: Every delivery is accompanied by a verified Certificate of Analysis (CoA). We ensure strict adherence to specifications for chemical purity, moisture content, and particle size distribution (PSD), enabling predictable blending, granulation, and compression behavior.

Technical Specifications for QA & R&D

The structural and chemical integrity of the active ingredient dictates the bioavailability and safety of the finished drug. Morgan’s Aprocitentan API is subject to rigorous analytical testing to meet international pharmacopeial standards.

• Chemical Name: N-[5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]pyrimidin-4-yl]-N'-propylsulfuric diamide
• CAS Number: 1103522-80-0
• Appearance: White to off-white crystalline solid
• Molecular Formula: C21H27Br2N5O6S
• Molecular Weight: 546.2 g/mol
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility: Detailed solubility parameters across standard organic solvents and aqueous buffers are available in Morgan's technical data sheet for dissolution profiling.

Manufacturing and Handling Guidelines

As an Endothelin Receptor Antagonist, Aprocitentan is a highly potent therapeutic compound with documented teratogenic properties. Facilities processing this API must enforce stringent occupational exposure limits (OEL).

• Storage Conditions: Store the raw API in well-closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol to prevent chemical degradation.
• Occupational Safety and Teratogenicity: The ETRA class carries severe warnings for embryofetal toxicity. Manufacturing personnel must adhere to advanced containment protocols. Processing requires high-level Personal Protective Equipment (PPE), including P3/N95 industrial respirators, double-layered nitrile gloves, and full protective suits. Weighing, milling, and compounding must be executed within closed-loop isolators or high-containment glove boxes to prevent inhalation of airborne particulates and dermal absorption.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.